Page last updated: 2024-11-04

sulfamethoxazole and Hematologic Malignancies

sulfamethoxazole has been researched along with Hematologic Malignancies in 2 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abouraya, M1
Sacco, JC1
Kahl, BS1
Trepanier, LA1
Vasconcelles, MJ1
Bernardo, MV1
King, C1
Weller, EA1
Antin, JH1

Trials

1 trial available for sulfamethoxazole and Hematologic Malignancies

ArticleYear
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:1

    Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Ma

2000

Other Studies

1 other study available for sulfamethoxazole and Hematologic Malignancies

ArticleYear
Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.
    British journal of clinical pharmacology, 2011, Volume: 71, Issue:4

    Topics: Adult; Aged; Anti-Infective Agents; Ascorbic Acid; Case-Control Studies; Cell Proliferation; Cytochr

2011